{
    "2020-12-02": [
        [
            {
                "time": "",
                "original_text": "康泰生物核心产品销售预测：未来四联疫苗的销量和单剂均价将继续增加",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "四联疫苗",
                        "销量",
                        "单剂均价",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【医药】国家医保谈判在即，创新产业链依然值得关注——医药行业周报——中性",
                "features": {
                    "keywords": [
                        "国家医保",
                        "谈判",
                        "创新产业链",
                        "医药行业",
                        "中性"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "创新药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "深度*公司*康泰生物(300601)：核心品种快速放量 研发工作稳步推进",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "核心品种",
                        "放量",
                        "研发",
                        "推进"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中泰证券：新冠疫苗数据持续积极，逐步进入兑现期，持续看好板块成长",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "新冠疫苗",
                        "数据",
                        "积极",
                        "兑现期",
                        "板块成长"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}